Answers are grounded in this paper and cite their sources.
Randomized trial compares single-dose fosfomycin trometamol to multiple-dose cotrimoxazole in women with urinary tract infections, suggesting effective treatment options.
A randomized trial, comparing a single dose treatment of fosfomycin trometamol (FT, 3 g) versus a 3-times daily regimen of cotrimoxazole (CTX, 960 mg) was carried out in women with uncomplicated urinary tract infections. Of 36 evaluable patients, 19 were treated with FT and 17 with TMP. The bacteriological results after 4 weeks of follow-up were in the FT group (n = 19): cure in 17 (89%), and failure in 2 (11%). For the CTX group (n = 17) the results were cure in 13 (76%), and failure in 4 (24%). Adverse events were reported in 3 patients on FT (2 diarrhoea, 1 epigastralgia) and in 2 on CTX (1 stain rash, 1 asthenia).
No takes yet. Share an insight, caveat, or question.
P. Crocchiolo (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: